circle-image

Short

Trend Resistance

Uptrend Above: 24100

Bull Market Above: 24310
circle-image

Term

Trend Point Acts

Trend Point: 24070

My PCR: 0.86

621 Range 81

circle-image

View

Trend Suport

Down Below: 24030

Bear Market Below: 23770
Short Term View Historic Data

Nifty View Today: Friday 15 May 2026

Day Close

23689
Day High

23777
Day Low

23426
Day Avg

23631
14 May 2026
5 SMA

23694
10 SMA

23928
20 SMA

24074
50 SMA

23836
200 SMA

25040
RRP

146
R/S

0.71
RMR

1.4
SRP

205

Today View

Resist 2

24020
Resist 1

23850
Mid Point

23680
Suport 1

23500
Suport 2

23310
52W High

26373
52w Low

22182
52w Down

10.18%
52w Up

6.79%

Panic View

Resist 2

24340
Resist 1

24095
Mid Point

23660
Suport 1

23215
Suport 2

22930
5d High

24253
5d Low

23262
10d High

24482
10d Low

23262
Days High & Low 20d High

24601
20d Low

23262
50d High

25572
50d Low

22182
All Avg

23860
Nifty Historic Prediction Data

Nifty Last Five Days Moves

SNo. Date Day Close Day High Day Low 5 DMA 10 DMA 20 DMA 50 DMA 200 DMA
1 14 May 2026 23689 23777 23426 23694 23928 24074 23836 25040
2 13 May 2026 23412 23582 23262 23822 23976 24101 23872 25047
3 12 May 2026 23379 23757 23348 24005 24035 24122 23912 25055
4 11 May 2026 23815 23997 23799 24136 24106 24156 23959 25064
5 08 May 2026 24176 24253 24126 24197 24114 24154 23994 25071
Nifty Historic Data And Moving Avg

Go Back

STANDARD ENGINEERING TECHNOLOGY LIMITED Company has entered into a Target-Based Conditional Distr...

Posted: 06 Mar 2026

STANDARD ENGINEERING TECHNOLOGY LIMITED Company has entered into a Target-Based Conditional Distribution Agreement with API Pharma Pharmaceutical Trading L.L.C, for the Middle East Region as part of its export expansion strategy. The agreement provides for an initial three (3) year performance period with defined annual and cumulative business targets. Subject to achievement of these milestones, the arrangement shall continue for a total tenure of upto ten (10) years. This arrangement is intended to strengthen the Company’s export presence in the Middle East region across: Pharmaceutical manufacturing facilities, Biopharmaceutical and life sciences, Food & Beverages and other process industries. The Middle East region continues to witness sustained investments in pharmaceutical self-sufficiency, biopharma capacity creation, food security programs and diversified industrial infrastructure under long-term economic transformation initiatives. The agreement enables the Company to participate in such export-driven growth opportunities through a performance-linked and riskcalibrated model. While mindful of evolving geopolitical developments in certain parts of the middle east region, the agreement has been prudently structured with commercial protections and periodic review mechanisms.

Market Bits

"In investing, what is comfortable is rarely profitable." — Robert Arnott

Be prepared to invest in a down market and to "get out" in a soaring market, as per the philosophy of Warren Buffett.